title: Adipose tissue-derived stromal cells primed in vitro with paclitaxel acquire anti-tumor activity.
abstract: Many strategies, including those based on genetically modified Mesenchymal Stromal Cells (MSCs), have been developed in recent years in order to obtain high concentrations of anticancer drugs effective on tumor mass. In previous studies, we showed that human and murine bone marrow-derived MSCs (BM-MSCs) and human skin-derived stromal fibroblasts (hSDFs) acquired strong anti-tumor capacity, both in vitro and in vivo, once primed with Paclitaxel (PTX). In this report we investigate whether adipose tissue-derived MSCs (AT-MSCs) behave similarly to BM-MSCs in their uptake and release of PTX in sufficient amounts to inhibit tumor proliferation in vitro. According to a standardized procedure, PTX primed AT-MSCs (AT-MSCsPTX) were washed and then subcultured to harvest their conditioned medium, which was then tested to evaluate its in vitro anti-tumor potential. We observed that AT-MSCsPTX were able to uptake PTX and release it in a time-dependent manner and that the released drug was active in vitro against proliferation of leukemia, anaplastic osteosarcoma, prostatic carcinoma and neuroblastoma cell lines. These data confirm that AT-MSCs, as well as BM-MSCs, can be loaded in vitro with anti-cancer drugs. While the harvesting of BM-MSCs requires invasive procedures, AT-MSCs can be prepared from fat samples taken with little patient discomfort. For this reason, this source of stromal cells represents an important alternative to BM-MSCs in developing new tools for carrying and delivering anti-cancer drugs into tumor microenvironments.
authors.affiliation: Department of Biomedical, Surgical and Dental Sciences, University of Milan, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Bonomi
authors.forename: V
authors.initials: V
authors.lastname: Coccè
authors.forename: L
authors.initials: L
authors.lastname: Cavicchini
authors.forename: F
authors.initials: F
authors.lastname: Sisto
authors.forename: M
authors.initials: M
authors.lastname: Dossena
authors.forename: P
authors.initials: P
authors.lastname: Balzarini
authors.forename: N
authors.initials: N
authors.lastname: Portolani
authors.forename: E
authors.initials: E
authors.lastname: Ciusani
authors.forename: E
authors.initials: E
authors.lastname: Parati
authors.forename: G
authors.initials: G
authors.lastname: Alessandri
authors.forename: A
authors.initials: A
authors.lastname: Pessina
mesh_terms: D000273:Adipose Tissue / Q000166:cytology*; D000972:Antineoplastic Agents, Phytogenic / Q000494:pharmacology*; D045744:Cell Line, Tumor; D049109:Cell Proliferation / Q000187:drug effects; D006801:Humans; D059630:Mesenchymal Stem Cells / Q000378:metabolism*; D017239:Paclitaxel / Q000494:pharmacology*
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D017239:Paclitaxel